Skip to main content

Table 2 Surgical outcomes of study participants (n = 329)

From: Effects of body mass index and serum albumin on overall survival in patients with cancer undergoing pancreaticoduodenectomy: a single-center retrospective cohort study

Variables

Total (n = 329)

Group 1 (n = 258)

Group 2 (n = 71)

P-value

Group I (n = 89)

Group II (n = 240)

P-value

Operation type (n/%)

0.933

  

0.753

 Open

302 (91.8)

237 (91.9)

65 (91.5)

81 (91.0)

221 (92.1)

 Laparoscopy

27 (8.2)

21 (8.1)

6 (8.5)

8 (9.0)

19 (7.9)

Surgical type (n/%)

0.935

  

0.076

 PD

196 (59.6)

154 (59.7)

42 (59.2)

46 (51.7)

150 (62.5)

 PPPD

133 (40.4)

104 (40.3)

29 (40.8)

43 (48.3)

90 (37.5)

Operation time (min)

255.0 (210.0–307.8)

245.0 (207.0–305.5)

270.0 (240.0–316.0)

0.028

245.0 (212.5–305.0)

255.0 (210.0–308.0)

0.686

Estimated blood loss (ml)

200.0 (200.0–400.0)

200.0 (200.0–400.0)

200.0 (150.0–400.0)

0.667

200.0 (162.5–300.0)

200.0 (200.0–400.0)

0.118

Transfusion (n/%)

68 (21.4)

53 (21.1)

15 (22.4)

0.821

19 (22.1)

49 (21.1)

0.851

Hospital LOS (days)

19.0 (15.0–27.0)

18.3 (14.0–27.0)

20.0 (15.5–29.0)

0.197

20.0 (15.0–28.0)

19.0 (14.3–27.0)

0.622

Postoperative LOS (days)

14.0 (10.0–21.0)

13.5 (10.0–20.3)

14.0 (11.0–25.0)

0.206

14.0 (10.0–21.0)

14.0 (10.0–21.0)

0.983

Major complication (n/%)

131 (39.8)

100 (38.8)

31 (43.7)

0.455

41 (46.1)

90 (37.5)

0.158

DGE (n/%)

52 (15.8)

41 (15.9)

11 (15.5)

0.935

16 (18.0)

36 (15.0)

0.511

Pancreatic fistula (n/%)

61 (18.5)

42 (16.3)

19 (26.8)

0.044

16 (18.0)

45 (18.8)

0.873

Biliary leakage (n/%)

7 (2.1)

5 (1.9)

2 (2.8)

0.647

8 (3.3)

8 (3.3)

8(3.3)

Chyle leakage (n/%)

6 (1.8)

5 (1.9)

1 (1.4)

1.000

1 (1.1)

5 (2.1)

1.000

Hemorrhage (n/%)

16 (4.9)

12 (4.7)

4 (5.6)

0.756

8 (9.0)

8 (3.3)

0.034

Wound infection (n/%)

13 (4.0)

12 (4.7)

1 (1.4)

0.313

4 (4.5)

9 (3.8)

0.754

Abdominal infection (n/%)

41 (12.5)

31 (12.0)

10 (14.1)

0.640

11 (12.4)

30 (12.5)

0.973

90-day readmission (n/%)

18 (5.5)

13 (5.0)

5 (7.1)

0.553

7 (7.9)

11 (4.6)

0.277

Reoperation (n/%)

7 (2.1)

7 (2.7)

0 (0.0)

0.353

3 (3.4)

4 (1.7)

0.393

  1. Group 1, BMI < 25 kg/m2; group 2 ≥ 25 kg/m2; group I, serum albumin < 35 g/L; group II, serum albumin ≥ 35 g/L
  2. DGE delayed gastric emptying, LOS length of stay, PD pancreaticoduodenectomy, PPPD pylorus-preserving pancreaticoduodenectomy